While free radicals and inflammation constitute major routes of neuronal injury occurring in neurodegenerative diseases, neither antioxidants nor nonsteroidal anti-inflammatory drugs (NSAIDs) have shown significant efficacy in human clinical trials. To explore the possibility that concurrent blockade of free radicals and PGE 2 -mediated inflammation might constitute a safe and effective therapeutic approach to certain neurodegenerative diseases, we have 
Introduction
Extensive evidence supports the central role of free radicals in the pathogenesis of amyotrophic lateral sclerosis (ALS) as well as other neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). Elevated oxidative products of protein, DNA, and lipid have been reported in the brain, spinal cord, and cerebrospinal fluid (CSF) in subjects with ALS [1] [2] [3] [4] [5] . Transgenic (SOD1 G93A ) mice that overexpress mutant SOD1
in familial ALS show motor neuron degeneration, movement deficit, and decreased survival rates 6 . In SOD1 G93A mice, oxidative stress is induced in spinal cord regions known to undergo the pathological changes in ALS [7] [8] . Excess accumulation of pro-oxidants such as iron is also observed and expected to cause neurodegeneration in familial as well as sporadic forms of ALS [9] [10] . A causative role for oxidative stress in the neurodegenerative pathology is supported by experimental findings that administration of antioxidants reduces neurological deficits apparent in SOD1 G93A mice 8, [11] [12] . However, two clinical trials using oral supplementation of vitamin E at either 500 mg/d for 12 months or 1500 mg/d for 18 months produced no beneficial effect on mortality in ALS patients [13] [14] . The therapeutic potential of anti-oxidants such as vitamin E, N-acetylcysteine and Coenzyme Q 10 that were advanced to clinical trial for ALS was limited by side effects and poor BBB permeability [15] [16] [17] . Anti- -induced ROS production and neuronal death (Fig. 1a) (Fig. 2c) . Oral administration of 200 mg/kg ibuprofen and 300 mg/kg aspirin caused severe gastric damage 24 h later (Fig. 2d) . Celecoxib, a selective COX-2 inhibitor, also produced mild gastric damage at an extremely high dose of 1000 mg/kg. . Genetic deletion of mPGES-1 was shown to reduce levels of PGE 2 in the CSF and fever following exposure to peripheral LPS injection 46 , suggesting that mPGES-1-dependent PGE 2 production is a mediator of CNS inflammation. Increased expression of mPGES-1 was also observed in neurons, astrocytes, and microglia as well as endothelial cells in postmortem brain of AD 47 .
We found that levels of PGE 2 and mPGES-1 were significantly increased in the lumbar spinal cord of SOD1 G93A mice. The latter was observed in neurons, astrocytes, microglia, and endothelial cells in the ventral horn undergoing widespread neuronal death and inflammation 
